Wildcat Capital Management, LLC Uro Gen Pharma Ltd. Transaction History

Wildcat Capital Management, LLC

$289 Million
Q1 2024

A detailed history of Wildcat Capital Management, LLC transactions in Uro Gen Pharma Ltd. stock. As of the latest transaction made, Wildcat Capital Management, LLC holds 495,606 shares of URGN stock, worth $7.5 Million. This represents 2.57% of its overall portfolio holdings.

Number of Shares

495,606

Previous 495,606 -0.0%

Holding current value

$7.5 Million

Previous $7.43 Million -0.0%

% of portfolio

2.57%

Previous 2.57%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 11, 2023	BUY	$8.75 - $14.29 $4.34 Million - $7.08 Million	495,606 New	495,606 $5.13 Million
Q1 2023 May 12, 2023	SELL	$7.99 - $11.02 $299,888 - $413,613	-37,533 Reduced 7.04%	495,606 $4.58 Million
Q1 2021 May 17, 2021	SELL	$17.99 - $26.96 $12.9 Million - $19.4 Million	-719,146 Reduced 57.43%	533,139 $10.4 Million
Q3 2020 Nov 13, 2020	BUY	$18.81 - $26.42 $6.62 Million - $9.3 Million	352,137 Added 39.12%	1,252,285 $24.2 Million
Q1 2020 Apr 09, 2020	SELL	$13.68 - $34.6 $3.5 Million - $8.85 Million	-255,714 Reduced 22.12%	900,148 $16.1 Million

Q4 2019 Feb 14, 2020	BUY	$21.11 - $34.86 $2.11 Million - $3.48 Million	99,800 Added 9.45%	1,155,862 $38.6 Million
Q3 2019 Nov 14, 2019	BUY	$23.83 - $36.44 $5.07 Million - $7.75 Million	212,697 Added 25.22%	1,056,062 $25.2 Million
Q2 2019 Aug 14, 2019	BUY	$32.75 - $40.35 $2.11 Million - $2.6 Million	64,362 Added 8.26%	843,365 $30.3 Million
Q1 2019 May 15, 2019	BUY	$35.47 - $54.55 $5.91 Million - $9.08 Million	166,509 Added 27.19%	779,003 $28.8 Million
Q4 2018 Feb 13, 2019	BUY	$38.35 - $50.39 $9.09 Million - $11.9 Million	237,015 Added 63.12%	612,494 $26.4 Million
Q3 2018 Nov 13, 2018	BUY	$41.65 - $51.7 $5.17 Million - $6.41 Million	124,020 Added 49.32%	375,479 $17.7 Million
Q2 2018 Aug 13, 2018	BUY	$48.35 - $65.33 $3.37 Million - $4.56 Million	69,757 Added 38.39%	251,459 $12.5 Million
Q1 2018 May 15, 2018	BUY	$38.64 - $57.54 $2.1 Million - $3.13 Million	54,389 Added 42.72%	181,702 $9.03 Million
Q4 2017 Feb 14, 2018	SELL	$27.28 - $43.26 $209,701 - $332,539	-7,687 Reduced 5.69%	127,313 $4.74 Million
Q2 2017 Aug 14, 2017	BUY	N/A	135,000	135,000 $2.44 Million

Others Institutions Holding URGN

# of Institutions

113

Shares Held

24M

Call Options Held

46.9K

Put Options Held

44.3K

View Full List

About UroGen Pharma Ltd.

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $344M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

More about URGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wildcat Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wildcat Capital Management, LLC with notifications on news.

Account

Wildcat Capital Management, LLC Uro Gen Pharma Ltd. Transaction History